Greater Joint and Skin Improvement With Ixekizumab vs Adalimumab in Patients With Psoriatic Arthritis
Researchers determined the efficacy and safety of ixekizumab vs adalimumab in bionaive patients with psoriatic arthritis.
Psoriatic Arthritis
Diabetes, CVD, and PsA May Be Prevalent in Patients With Palmoplantar Plaque Psoriasis
The relationship of palmoplantar plaque psoriasis and comorbidities known to be associated with generalized plaque psoriasis were examined.
Top US Experts in Psoriatic Arthritis Identified
Expertscape has developed an online physician ranking search tool to help identify the providers and researchers with leading expertise in psoriatic arthritis and other specialties.
Sleep Disturbances, Fatigue, and Depression Common Among Patients With Psoriatic Arthritis
Researchers explored the occurrence of sleep disturbances, fatigue, and anxiety/depression in patients with psoriatic arthritis.
Methotrexate Superior to Sulfasalazine as First-Line csDMARD Monotherapy in Patients With PsA
Researchers evaluated drug retention and predictors for drug retention among patients with psoriatic arthritis receiving first-line conventional synthetic DMARD monotherapy.
Disease Activity Tool, Carotid Plaque Predicts Cardiovascular Events in Patients with Psoriatic Arthritis
Researchers examined whether a disease activity tool and the presence of carotid plaques can predict cardiovascular events, independent of traditional risk factors, in psoriatic arthritis.
Evaluating Methotrexate Monotherapy for Minimal Disease Activity Achievement in Early PsA
Researchers assessed the response to methotrexate monotherapy in newly diagnosed patients with psoriatic arthritis.
Psoriatic Arthritis May Be a Risk Factor for Low BMD, But Association Not Genetically Determined
In this observational study, researchers assessed the association between psoriasis, psoriatic arthritis, and osteoporosis.
Current Smoking Associated With Axial Involvement and Radiographic Sacroiliitis in Psoriatic Arthritis
Researchers evaluated the frequency of smoking and other risk factors of axial psoriatic arthritis.
Ixekizumab May Prevent Reactivation of Tuberculosis in Patients With Latent Tuberculosis Infection
Study data support the use of therapeutic antibodies targeting IL-17A, such as ixekizumab, in patients with latent tuberculosis infection.
-
Loading...
-
Loading...
Next post in Spondyloarthritis
